Conversely, Ret gain of function mutations are causal for autosomal dominant MEN2 (multiple endocrine neoplasia type 2) type medullary thyroid carcinoma (Lairmore et al., 1993; Almeida and Hoff, 2012). This evidence concerns the gene RET and medullary thyroid gland carcinoma.